MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway

BACKGROUND: Trastuzumab resistance is almost inevitable in the management of human epidermal growth factor receptor (HER) 2 positive breast cancer, in which phosphatase and tensin homolog deleted from chromosome 10 (PTEN) loss is implicated. Since metadherin (MTDH) promotes malignant phenotype of br...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Du, Cheng, Yi, Xiaomin, Liu, Wenchao, Han, Tao, Liu, Zhaozhe, Ding, Zhenyu, Zheng, Zhendong, Piao, Ying, Yuan, Jianlin, Han, Yaling, Xie, Manjiang, Xie, Xiaodong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2014
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4254009/
https://ncbi.nlm.nih.gov/pubmed/25417825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-869
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia